Skip to content

FDA approves generic version of Novo Nordisk’s GLP-1 diabetes drug Victoza

  • by
Spread the love

 NBC News Top StoriesThe Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.

​The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.  

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *